Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials
JOURNAL OF INFECTIOUS DISEASES(2024)
Key words
BMI,cabotegravir,HIV-1,long-acting,rilpivirine
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined